FindTrial
Sign In

Daidzein-Decorated Gold Nanoparticles as a Novel Antimicrobial Strategy Against Carbapenem-Resistant Enterobacteriaceae

Daidzein-Decorated Gold Nanoparticles as a Novel Antimicrobial Strategy Against Carbapenem-Resistant Enterobacteriaceae

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500097292
Enrollment
Unknown
Registered
2025-02-17
Start date
2025-02-28
Completion date
Unknown
Last updated
2025-02-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Treatment group:Treatment of gold nanoparticles modified with daidzein
Control group:no medicine

Sponsors

The First Affiliated Hospital of Wenzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1.Clinical patients with carbapenem-resistant enterobacter were isolated;

Exclusion criteria

Exclusion criteria: 1.Clinical data are incomplete;

Design outcomes

Primary

MeasureTime frame
Minimum inhibitory concentration;Growth curve and time killing;survival rate;—

Countries

China

Contacts

Public ContactTieli Zhou

The First Affiliated Hospital of Wenzhou Medical University

wyztli@163.com+86 13957745093

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026